Parkman Healthcare Partners LLC logo

Parkman Healthcare Partners LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Parkman Healthcare Partners LLC with $910.1M in long positions as of Q3 2025, 93% allocated to Healthcare, and 32% concentrated in top 10 positions.

Portfolio Value
$910.1M
Top 10 Concentration
32%
Top Sector
Healthcare (93%)
US Exposure
89%
Market Cap Focus
Large Cap
Countries
6

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 93.20%HealthcareTechnology: 1.30%
Healthcare
93.20%
Technology
1.30%

Industry Breakdown

11 industries across all sectors

Biotechnology: 41.78%BiotechnologyMedical - Devices: 25.44%Medical - DevicesMedical - Diagnostics & Research: 6.68%Medical - Healthcare Information Services: 4.61%Medical - Healthcare Plans: 3.14%Drug Manufacturers - General: 2.84%5 more: 9.99%5 more
Biotechnology
Healthcare
41.78%
Medical - Devices
Healthcare
25.44%
Medical - Diagnostics & Research
Healthcare
6.68%
Medical - Healthcare Information Services
Healthcare
4.61%
Medical - Healthcare Plans
Healthcare
3.14%
Drug Manufacturers - General
Healthcare
2.84%
Drug Manufacturers - Specialty & Generic
Healthcare
2.48%
Medical - Distribution
Healthcare
2.42%
Medical - Instruments & Supplies
Healthcare
2.15%
Medical - Care Facilities
Healthcare
1.66%
Information Technology Services
Technology
1.28%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 0.84%Large Cap ($10B - $200B): 40.84%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 23.70%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 30.04%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 3.16%N/A (ETF or Unknown): 1.44%
Mega Cap (> $200B)
0.84%
Large Cap ($10B - $200B)
40.84%
Mid Cap ($2B - $10B)
23.70%
Small Cap ($300M - $2B)
30.04%
Micro Cap ($50M - $300M)
3.16%
N/A (ETF or Unknown)
1.44%

Portfolio Concentration

Top 10 Holdings %
31.95%
Top 20 Holdings %
51.57%
Top 50 Holdings %
84.23%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
89.39%
International
10.61%
Countries
6
Largest Int'l Market
Netherlands - 4.67%
United States of America
89.39% ($813.6M)
82 holdings
Netherlands
4.67% ($42.5M)
2 holdings
Bermuda
2.87% ($26.1M)
1 holdings
United Kingdom
1.59% ($14.4M)
1 holdings
Canada
0.78% ($7.1M)
1 holdings
Israel
0.71% ($6.4M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
7.5 quarters
Avg. Top 20
6.4 quarters
Avg. All Positions
5.9 quarters
Median Holding Period
4 quarters
Persistence Rate
51.69%
Persistent Holdings Weight
57.59%
Persistent Positions
46
Longest Held
Mannkind Corporation logo
Mannkind CorporationMNKD - 23 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.40%
Avg. Position Weight
1.12%
Largest Position
Boston Scientific Corp. logo
Boston Scientific Corp.BSX - 4.66%
Largest Ownership Stake
InspireMD, Inc. logo
InspireMD, Inc.NSPR - 5.85%
Avg. Ownership Stake
0.58%
Ownership Stake >5%
1
Ownership Stake >1%
16

Historical (Since Q4 2019)

Avg. New Position
1.03%
Avg. Ownership Stake
0.42%
Largest Position
AVROBIO, Inc. Common Stock logo
AVROBIO, Inc. Common StockAVRO - 25.63% (Q1 2020)
Largest Ownership Stake
PLUS THERAPEUTICS, Inc. Common Stock logo
PLUS THERAPEUTICS, Inc. Common StockPSTV - 6.91% (Q2 2022)

Portfolio Turnover

Current Quarter

Turnover Ratio
23.8%
Value Traded
$216.42M
Positions Added
10
Positions Exited
11

Historical (Since Q4 2019)

Avg. Turnover Ratio
26.6%
Avg. Positions Added
15
Avg. Positions Exited
15
Highest Turnover
50.0%
Q4 2019
Lowest Turnover
17.2%
Q3 2020

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.